{"id":8005,"date":"2020-09-03T04:38:46","date_gmt":"2020-09-03T04:38:46","guid":{"rendered":"http:\/\/www.16news.com.au\/?p=8005"},"modified":"2020-09-03T04:38:46","modified_gmt":"2020-09-03T04:38:46","slug":"funding-boost-for-covid-19-research","status":"publish","type":"post","link":"http:\/\/www.16news.com.au\/index.php\/2020\/09\/03\/funding-boost-for-covid-19-research\/","title":{"rendered":"Funding Boost For Covid-19 Research"},"content":{"rendered":"

The Australian Government is backing several Australian research projects aimed at finding breakthrough treatments, diagnostics and \u2013 the ultimate \u2013 a vaccine in the fight against COVID-19.
\nOur Government has allocated $10.4 million for 13 early stage biomedical projects through Biomedical Translation Bridge (BTB) program, which forms part of the landmark Medical Research Future Fund (MRFF).
\nFive of them are COVID-19 research projects receiving $4.1 million. A key project, conducted by the University of Melbourne, involves developing an innovative ventilated hood for patients in isolation.
\nThe Hood provides better respiratory treatment for patients, reducing the need for invasive ventilation, and also gives hospital staff greater protection from COVID-19, reducing viral levels in the immediate surroundings.
\nThe novel hood is e\ufb00ective, comfortable, reusable and can be rapidly improved for urgent supply to Australian hospitals, clinics, GP surgeries, and beyond. A smaller, mobile version under development will have signi\ufb01cant health benefits in developing countries and for patient transport.
\nOther COVID-19 research projects include a vaccine candidate being developed in South Australia, a new treatment for respiratory complications of COVID-19, a preventive nasal spray, and a rapid response test to predict how severely the disease will progress.
\nThe remaining eight projects, receiving $6.3 million, will help patients of the future with new treatments and diagnostics for conditions such as muscular dystrophy, breast cancer, metabolic and fibrotic disease, prostate cancer, ataxia, antimicrobial resistance and the Zika virus.
\nIndustry partners have contributed a further $28 million to the 13 projects, complementing our Government\u2019s investment of $10.4 million \u2013 this means a total of $38.4 million is being invested into the biomedical sector.
\nThe BTB is a four year $22.3 million MRFF program, operated by MTPConnect.
\nIt helps researchers transform their ideas into new treatments to help tomorrow\u2019s patients. These investments are from the second and third rounds of the BTB program.
\nResearch is a key weapon in the fight against COVID-19.
\nThe emphasis of the BTB program is on rapid translation of ideas into new products and treatments that will make a real difference to patients, both in Australia and globally.
\nResearch is also about jobs and exports \u2013 which is particularly important as we tackle both the social and economic disruption of the pandemic to our lives and livelihoods.
\nFurther details of the 13 successful projects are listed here.
\nBTB Round 2 recipients:<\/strong>
\nBard1 Life Sciences Limited<\/strong><\/a>, VIC<\/strong>\u00a0(ASX listed)\u00a0<\/strong>is developing a novel high-throughput SubB2M-based liquid biopsy blood tests for breast cancer screening and monitoring based on a unique cancer-specific probe.
\nCincera Therapeutics Pty Ltd<\/strong><\/a>, VIC\/SA<\/strong>\u00a0<\/strong>is developing a new drug treatment for Metabolic and Fibrotic Disease.
\nEnvision Sciences Pty Ltd<\/strong><\/a>, SA<\/strong>\u00a0is developing diagnosis and prognostic detection methods for prostate cancer, using blood and tissue samples.
\nLBT Innovations Limited<\/strong><\/a>, SA<\/strong>\u00a0(ASX listed)<\/strong>\u00a0is developing APAS\u00ae-AMR: An Automated Plate Assessment System for Anti-Microbial Resistance using Artificial Intelligence.
\nPharmaxis Ltd<\/strong><\/a>, NSW<\/strong>\u00a0(ASX listed)<\/strong>\u00a0is developing compound PXS-4699 with tailored dual action to treat Duchenne Muscular Dystrophy.
\nThe University of Adelaide<\/strong><\/a>, SA<\/strong>\u00a0is developing a world-first needle-free Zika virus vaccine.
\nThe Florey Institute of Neuroscience and Mental Health<\/strong><\/a>, VIC<\/strong>\u00a0is developing a device for guiding therapy in ataxia and imbalance.
\nUniQuest Pty Ltd<\/strong><\/a>, QLD<\/strong>\u00a0<\/strong>is developing first-in-class drug candidates for the treatment of prostate and other cancers.
\nBTB COVID-19 Round 3 recipients:<\/strong>
\nDimerix Bioscience Pty Ltd<\/strong><\/a>, VIC<\/strong>\u00a0(ASX listed)<\/strong>\u00a0is developing a new treatment for respiratory complications as a result of COVID-19 in a global clinical study with a potential fast track pathway to clinical practice.
\nStarpharma Pty Ltd<\/strong><\/a>, VIC<\/strong>\u00a0(ASX listed)<\/strong>\u00a0is developing an intranasal spray, utilising an already-marketed, broad-spectrum antiviral dendrimer for COVID-19 and potential use in future pandemics.
\nSpeeDx Pty Ltd<\/strong><\/a>, NSW<\/strong>\u00a0is developing the InSignia(TM) Respiratory Virus Host Response test \u2013 a rapid-response COVID-19 assay to enhance Australia\u2019s current and future pandemic preparedness.
\nUniversity of Melbourne<\/strong><\/a>, VIC<\/strong>\u00a0is developing a novel ventilated hood for patient isolation to provide better patient respiratory treatment and protect hospital sta\ufb00 from COVID-19.
\nVaxine Pty Ltd<\/strong><\/a>, SA<\/strong>\u00a0is developing an Australian COVID-19 vaccine, COVAX-19\u00ae, which comprises of a recombinant spike protein antigen formulated with Vaxine\u2019s proprietary Advax\u2122 adjuvant.<\/p>\n","protected":false},"excerpt":{"rendered":"

The Australian Government is backing several Australian research projects aimed at finding breakthrough treatments, diagnostics and \u2013 the ultimate \u2013 a vaccine in the fight against COVID-19. Our Government has allocated $10.4 million for 13 early stage biomedical projects through Biomedical Translation Bridge (BTB) program, which forms part of the landmark Medical Research Future Fund … Continue reading “Funding Boost For Covid-19 Research”<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[2],"tags":[],"class_list":["post-8005","post","type-post","status-publish","format-standard","hentry","category-aussie"],"_links":{"self":[{"href":"http:\/\/www.16news.com.au\/index.php\/wp-json\/wp\/v2\/posts\/8005","targetHints":{"allow":["GET"]}}],"collection":[{"href":"http:\/\/www.16news.com.au\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/www.16news.com.au\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/www.16news.com.au\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"http:\/\/www.16news.com.au\/index.php\/wp-json\/wp\/v2\/comments?post=8005"}],"version-history":[{"count":0,"href":"http:\/\/www.16news.com.au\/index.php\/wp-json\/wp\/v2\/posts\/8005\/revisions"}],"wp:attachment":[{"href":"http:\/\/www.16news.com.au\/index.php\/wp-json\/wp\/v2\/media?parent=8005"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/www.16news.com.au\/index.php\/wp-json\/wp\/v2\/categories?post=8005"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/www.16news.com.au\/index.php\/wp-json\/wp\/v2\/tags?post=8005"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}